References
- Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323(8):709–1097.
- Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77.
- Yao XH, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(0):E009.
- Tao J, Song Z, Yang L, et al. Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department. Br J Dermatol. 2020;182(6):1477–1478.
- Darlenski R, Tsankov N. Covid-19 pandemic and the skin: what should dermatologists know? Clin Dermatol. 2020. DOI:10.1016/j.clindermatol.2020.03.012
- American Academy of Dermatology: Guidance on the use of medications during COVID-19 outbreak. American Academy of Dermatology Association. 2020; [updated 2020 April 13; cited 2020 May 18]. Available from: https://assets.ctfassets.net/1ny4yoiyrqia/PicgNuD0IpYd9MSOwab47/5e6d85324e7b5aafed45dde0ac4ea21eGuidance_on_medications_AHTF_approved_April_15.pdf.
- Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228):e52.
- Yang JZ, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
- MDS/SDH COVID-19 Task Force: COVID-19 Medical and Inpatient Dermatology Responses for Patients. Medical Dermatology Society2020 [cited 2020 May 18]. Available from: https://www.meddermsociety.org/covid-19-medical-inpatient-dermatology-responses-patients/.
- IPC Statement on the Coronavirus (COVID-19) Outbreak International Psoriasis Council 2020. [updated 2020 March 11; cited 2020 May 18]. Available from: https://www.psoriasiscouncil.org/blog/Statement-on-COVID-19-and-Psoriasis.htm.
- International Eczema Council Statement on COVID-19. 2020; [cited 2020 May 18]. Available from: https://www.eczemacouncil.org/news/iec-statement-on-covid-19/.
- Guy’s and St. Thomas’ Dermatology and coronavirus: frequently asked questions. NHS Foundation Trust. 2020; [cited 2020 May 18]. Available from: https://www.guysandstthomas.nhs.uk/our-services/dermatology/dermatology-and-coronavirus-frequently-asked-questions.aspx#na.
- Peter Foley CB. The Australasian College of Dermatologists: COVID-19 Biologics – Trial Patient information 2020; [updated 2020 March 24; cited 2020 May 18]. Available from: https://www.dermcoll.edu.au/wp-content/uploads/2020/03/COVID-19_Information-for-patients-receiving-biologics-1.pdf.
- NICE COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response.: National Institute for Health and Care Excellence 2020; [updated 2020 April 30; cited 2020 May 18]. Available from: https://www.nice.org.uk/guidance/ng169/resources/covid19-rapid-guideline-dermatological-conditions-treated-with-drugs-affecting-the-immune-response-pdf-66141909147589.
- Canadian Dermatology Association; Patient Information: COVID & Systemics. 2020; [updated 2020 March 27; cited 2020 May 18]. Available from: https://dermatology.ca/wp-content/uploads/2020/03/Systemic-Patients-March-27-2020-EN.pdf.
- American Academy of Dermatology COVID-19 Registry. 2020; [cited 2020 May 19]. Available from: https://www.aad.org/member/practice/coronavirus/registry.
- SECURE- Alopecia: Coronavirus & Alopecia Reporting Database.: Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion. 2020; [cited 2020 May 19]. Available from: https://securealopecia.covidderm.org/login/?next=/insight/.
- Global Hidradenitis Suppurativa COVID-19 Registry. 2020; [cited 2020 May 19]. Available from: https://hscovid.ucsf.edu/.
- PsoProtect: Psoriasis Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection. 2020; [cited 2020 May 19]. Available from: https://psoprotect.org/.
- SECURE-Psoriasis Registry Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion. 2020; [cited 2020 May 19]. Available from: https://school.wakehealth.edu/Departments/Dermatology/SECURE-Psoriasis.